PLATINUM2024

Breast Cancer Research Foundation

Save research. Save lives.

aka BCRF   |   New York, NY   |  http://www.bcrf.org
GuideStar Charity Check

Breast Cancer Research Foundation

EIN: 13-3727250


Mission

The Breast Cancer Research Foundation (BCRF) is dedicated to being the end of breast cancer by advancing the worlds most promising research. Founded by Evelyn H. Lauder in 1993, BCRF-funded investigators have been deeply involved in every major breakthrough in breast cancer prevention, diagnosis, treatment, survivorship, and metastasis. This year, BCRF has awarded $60.2 million in grants to support the work of more than 250 scientists at leading medical and academic institutions across 14 countries, making BCRF the largest private funder of breast cancer research worldwide. BCRF is also the highest-rated breast cancer research organization in the U.S. Visit www.bcrf.org to learn more.

Ruling year info

1993

Principal Officer

Mrs. Donna McKay

Main address

28 W. 44th Street, Suite 609

New York, NY 10036 USA

Show more contact info

EIN

13-3727250

Subject area info

Health

Population served info

Adults

Women and girls

NTEE code info

Cancer Research (H30)

Fund Raising and/or Fund Distribution (H12)

Cancer (G30)

Programs and results

What we aim to solve

SOURCE: Self-reported by organization

BCRF seeks to prevent and cure breast cancer by funding the most promising medical research. 200,000 women and men living with metastatic (stage 4) breast cancer urgently need new treatment options. The 4 million women and men who have survived a breast diagnosis need to know if they have been cured if they are at risk of disease recurrence. Breast cancer incidence is unacceptably high. New research-based initiatives for prevention and risk reduction are needed.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Breast Cancer Research Foundation (BCRF) Research Grant Program

The Breast Cancer Research Foundation’s grant application process is overseen by a voluntary group of renowned breast cancer research experts who comprise the BCRF Board of Scientific Advisors.  These Advisors invite proposals from deserving scientists who are pursuing new and creative projects related to breast cancer prevention, diagnosis and treatment, and in need of critical seed funds.  This Board reviews the proposals and submits an approved roster to the BCRF Board of Directors for funding authorization.  The average size of each annual grant is $250,000. Grant recipients are required to provide both narrative and financial progress reports twice a year.

Population(s) Served
Women and girls
Adults

Where we work

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Annual investment in breast cancer research grants

This metric is no longer tracked.
Totals By Year
Related Program

Breast Cancer Research Foundation (BCRF) Research Grant Program

Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

BCRF seeks to make breast cancer no longer life-threatening and to eventually eradicate breast cancer altogether through funding innovative clinical and translational research. BCRF supports the broadest portfolio of cancer research possible, supporting the entire spectrum from every angle, from prevention through treatments to survivorship. BCRF aims to develop, through research, more effective treatments that have fewer side effects than chemotherapy or other currently available treatments. BCRF aims to advance our knowledge about the risk factors and causes of breast cancer and develop evidence-based interventions to prevent and reduce the risk of breast cancer.

BCRF supports research in breast cancer all over the world through an innovative grant-making model. With the support of a world-renowned scientific advisory board, BCRF selects the best and brightest researchers in breast cancer and invites them to apply for funding. Because BCRF supports people and not projects, those that make it through the rigorous, peer-reviewed, selection process are empowered to pursue their most creative, innovative, and game-changing ideas. BCRF also knows that progress in research doesn't happen in silos. We foster collaborations by bringing together BCRF investigators for meetings and symposiums. The non-competitive grant applications also encourage the sharing of ideas, not keeping them private for their own grants.

At BCRF, the staff is driven and motivated, and many of whom have a personal connection to breast cancer. Every single employee is empowered, inspired, and united by the mission of doing everything we can to cure breast cancer and do so in record time. We work hard to raise the funds necessary to promote the most promising research. We attend conferences and speak with experts so we are always up to date on the latest research being conducted. With over 100 corporate partners, we are all working together to end breast cancer. BCRF is supported by a world-renowned scientific advisory board, chaired by Drs. Judy Garber from Dana-Farber Cancer Institute and Larry Norton, director of the Evelyn H. Lauder Breast Center at Memorial Sloan Kettering Cancer Center, who serves as the scientific director. Along with the other members of the SAB, they decide the research focus of BCRF and how we can chart the best path to a cure.

Deaths from breast cancer have decreased by 43 percent since 1989, and BCRF-supported investigators have been involved in every major breakthrough in breast cancer since our founding. Thanks to BCRF-funded research, we now know that breast cancer is not just one disease, but is made of many different subtypes, each responding differently to different treatments. We also know much more about genetic risk factors, like BRCA1 and BRCA2, but also other genes that can influence an individual's risk of being diagnosed with breast cancer. There are new diagnostic tests developed by BCRF investigators and new treatments being discovered. What's next is to end breast cancer. BCRF is currently in the process of developing even more innovative funding models to accelerate bringing the most brilliant, game-changing ideas out of the labs and into the hands of patients and families suffering from this devastating disease.

Revenue vs. expenses:  breakdown

SOURCE: IRS Form 990 info
NET GAIN/LOSS:    in 
Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2022 info

SOURCE: IRS Form 990

1.63

Average of 1.04 over 10 years

Months of cash in 2022 info

SOURCE: IRS Form 990

5.1

Average of 5.9 over 10 years

Fringe rate in 2022 info

SOURCE: IRS Form 990

25%

Average of 35% over 10 years

Funding sources info

Source: IRS Form 990

Assets & liabilities info

Source: IRS Form 990

Financial data

SOURCE: IRS Form 990

Breast Cancer Research Foundation

Revenue & expenses

Fiscal Year: Jul 01 - Jun 30

SOURCE: IRS Form 990 info

Fiscal year ending: cloud_download Download Data

Breast Cancer Research Foundation

Balance sheet

Fiscal Year: Jul 01 - Jun 30

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: cloud_download Download Data

Breast Cancer Research Foundation

Financial trends analysis Glossary & formula definitions

Fiscal Year: Jul 01 - Jun 30

SOURCE: IRS Form 990 info

This snapshot of Breast Cancer Research Foundation’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Business model indicators

Profitability info 2018 2019 2020 2021 2022
Unrestricted surplus (deficit) before depreciation $3,558,650 -$1,635,641 $17,245,490 $5,558,507 -$6,497,216
As % of expenses 4.6% -2.0% 29.8% 9.1% -9.3%
Unrestricted surplus (deficit) after depreciation $3,523,967 -$1,732,236 $17,116,685 $5,334,099 -$6,745,293
As % of expenses 4.6% -2.1% 29.5% 8.7% -9.7%
Revenue composition info
Total revenue (unrestricted & restricted) $78,996,006 $79,556,601 $76,216,662 $64,523,080 $84,528,969
Total revenue, % change over prior year 8.2% 0.7% -4.2% -15.3% 31.0%
Program services revenue 0.0% 0.0% 0.0% 0.0% 0.0%
Membership dues 0.0% 0.0% 0.0% 0.0% 0.0%
Investment income 0.5% 2.1% 2.5% 1.8% 2.1%
Government grants 0.0% 0.0% 0.0% 0.0% 1.5%
All other grants and contributions 99.7% 97.0% 97.5% 97.2% 95.8%
Other revenue -0.1% 0.9% 0.0% 1.0% 0.6%
Expense composition info
Total expenses before depreciation $76,851,480 $82,119,183 $57,806,822 $61,209,653 $69,635,959
Total expenses, % change over prior year 7.1% 6.9% -29.6% 5.9% 13.8%
Personnel 9.6% 9.5% 16.1% 14.4% 14.8%
Professional fees 4.9% 6.0% 7.8% 3.9% 3.6%
Occupancy 1.1% 1.4% 2.2% 2.1% 2.3%
Interest 0.0% 0.0% 0.0% 0.0% 0.0%
Pass-through 82.0% 80.4% 70.1% 77.0% 75.0%
All other expenses 2.4% 2.7% 3.9% 2.6% 4.4%
Full cost components (estimated) info 2018 2019 2020 2021 2022
Total expenses (after depreciation) $76,886,163 $82,215,778 $57,935,627 $61,434,061 $69,884,036
One month of savings $6,404,290 $6,843,265 $4,817,235 $5,100,804 $5,802,997
Debt principal payment $0 $0 $0 $0 $1,272,100
Fixed asset additions $173,474 $389,219 $0 $0 $0
Total full costs (estimated) $83,463,927 $89,448,262 $62,752,862 $66,534,865 $76,959,133

Capital structure indicators

Liquidity info 2018 2019 2020 2021 2022
Months of cash 2.5 6.0 9.0 4.2 5.1
Months of cash and investments 12.2 13.8 19.8 20.8 18.5
Months of estimated liquid unrestricted net assets 2.6 2.1 6.6 7.3 5.3
Balance sheet composition info 2018 2019 2020 2021 2022
Cash $16,164,031 $41,233,728 $43,416,233 $21,506,382 $29,363,786
Investments $62,283,942 $52,945,808 $52,174,881 $84,353,983 $77,829,779
Receivables $24,938,055 $14,304,535 $8,351,376 $10,577,001 $22,558,728
Gross land, buildings, equipment (LBE) $572,735 $961,953 $992,379 $1,135,163 $477,166
Accumulated depreciation (as a % of LBE) 61.8% 46.8% 58.4% 70.8% 94.8%
Liabilities (as a % of assets) 73.8% 75.9% 57.1% 52.2% 50.6%
Unrestricted net assets $16,737,105 $15,004,869 $32,121,554 $37,455,653 $30,710,360
Temporarily restricted net assets $4,072,890 $4,893,478 N/A N/A N/A
Permanently restricted net assets $6,550,000 $6,550,000 N/A N/A N/A
Total restricted net assets $10,622,890 $11,443,478 $13,042,405 $18,792,076 $33,481,533
Total net assets $27,359,995 $26,448,347 $45,163,959 $56,247,729 $64,191,893

Key data checks

Key data checks info 2018 2019 2020 2021 2022
Material data errors No No No No No

Operations

The people, governance practices, and partners that make the organization tick.

Documents
Form 1023/1024 is not available for this organization

Principal Officer

Mrs. Donna McKay

Number of employees

Source: IRS Form 990

Breast Cancer Research Foundation

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Compensation
Other
Related
Show data for fiscal year
Compensation data
Download up to 5 most recent years of officer and director compensation data for this organization

Breast Cancer Research Foundation

Highest paid employees

SOURCE: IRS Form 990

Compensation
Other
Related
Show data for fiscal year
Compensation data
Download up to 5 most recent years of highest paid employee data for this organization

Breast Cancer Research Foundation

Board of directors
as of 04/05/2024
SOURCE: Self-reported by organization
Board of directors data
Download the most recent year of board of directors data for this organization
Board co-chair

Mr. William Lauder

The Estee Lauder Companies Inc.


Board co-chair

Mrs. Kinga Lampert

Leonard A Lauder

The Estee Lauder Companies Inc.

Deborah Krulewitch

The Estee Lauder Companies Inc.

Efraim Grinberg

Kinga Lampert

Susan Hertog

Teruca Rullan

Popular, Inc.

Shelly Kivell

Larry Norton

Memorial Sloan Kettering Cancer Center

Laura Lang

Clarissa Alcock Bronfman

Thomas C. Quick

Abbe Raven

A&E Television Networks LLC

Kendra Scott

William Lauder

The Estée Lauder Companies Inc.

Kay Krill

ANN INC.

Cindy Citrone

Betsy Battle

Lone Peak Partners

Ellen Odoner

Weil, Gotshal & Manges LLP

Carlyn McCaffrey

Donna McKaay

The Breast Cancer Research Foundation

Judy E. Garber

Dana-Farber Cancer Institute

Jerome Bettis

Nina Garcia

Karen Hale

William S. Karol

Andrea Redmond

Kerone Vatel

Organizational demographics

SOURCE: Self-reported; last updated 4/26/2023

Who works and leads organizations that serve our diverse communities? Candid partnered with CHANGE Philanthropy on this demographic section.

Leadership

The organization's leader identifies as:

Race & ethnicity
White/Caucasian/European
Gender identity
Female, Not transgender
Sexual orientation
Heterosexual or Straight

Race & ethnicity

No data

Gender identity

No data

Transgender Identity

No data

Sexual orientation

No data

Disability

No data

Contractors

Fiscal year ending

Professional fundraisers

Fiscal year ending

SOURCE: IRS Form 990 Schedule G

Solicitation activities
Gross receipts from fundraising
Retained by organization
Paid to fundraiser